Integer Holdings Corporation
ITGRHealthcareNASDAQMedical Devices
Scan Results
Daily timeframePart of the healthcare sector, Integer Holdings Corporation (ITGR) is listed under Medical Devices. With a market capitalization of $3.24B, it sits in mid-cap territory. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Market Cap
$3.24B
Beta
0.64
P/E (TTM)
24.72
P/E (Fwd)
14.02
EPS (TTM)
$3.86
EPS (Fwd)
$6.81
ROE
8.6%
ROA
4.2%
Cash
$8.1M
Total Debt
$1.38B
Free CF
$98.1M
52W Change
-15.2%
Annual Financials
Cash vs Debt
Integer Holdings Corporation carries $1.38B in total debt against $8.1M in cash reserves — debt is roughly 170.2x the cash position. Managing this leverage effectively will be important for long-term financial stability. Free cash flow comes in at $98.1M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 8.6% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 4.2% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $1.33B (2022) to $1.85B (2025), reflecting a 39% increase over the period.
With a beta below 0.7, Integer Holdings Corporation typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. Integer Holdings Corporation carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing ITGR.